Delivery Order SPE2DR25D3103-SPE2DR26F9F55
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $5,404.53 firm fixed-price delivery order from the Defense Logistics Agency on October 22, 2025, for Dupixent 300 mg/2 mL syringes. The contract, which represents a non-set-aside competitive award, is scheduled for completion by October 23, 2025, with performance taking place at the contractor's Conshohocken facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,171.54 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Dupixent 300mg/2ml syringes valued at $44,390.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation and represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $19,042.85 to supply Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 6, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves...
- The Defense Logistics Agency awarded a $2,291.36 delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL syringes on October 14, 2025, with completion scheduled for October 15, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $16,240.29 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on September 25, 2025, with completion expected by September 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This...
- The Defense Logistics Agency awarded a $30,478.93 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,074.12 for Dupixent 300 mg/2 mL syringes on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, firm fixed-price contract requires delivery to the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $9,986.53 delivery order contract to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract requires performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,548.41 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F55Delivery Order
The Defense Logistics Agency awarded a $8,102.38 delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL syringes to be delivered to the company's facility in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by November 17, 2025. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a comprehensive range of pharmaceutical products and medical supplies to federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to fulfill diverse medical supply requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices, through competitive awards with the Defense Logistics Agency and its Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 11/14/25 |